title: Resurgence of interest in sexual dysfunction?
authors.affiliation: Global Pharma Consulting Ltd, Sittingbourne Research Centre, Kent, ME9 8PX, UK. m.wyllie@globalpharma.co.uk
authors.forename: Mike G
authors.initials: MG
authors.lastname: Wyllie
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use; D017277:Drug Approval; D004345:Drug Industry; D005260:Female; D006801:Humans; D008297:Male; D008389:Marketing of Health Services; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D012735:Sexual Dysfunction, Physiological / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D020018:Sexual Dysfunctions, Psychological / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D001562:Benzimidazoles; D010726:Phosphodiesterase Inhibitors; C098107:flibanserin